GoodRx(GDRX) - 2024 Q3 - Earnings Call Transcript

GoodRx Holdings, Inc. (NASDAQ:GDRX) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants Aubrey Reynolds – Director of Investor Relations Scott Wagner – Interim Chief Executive Officer Karsten Voermann – Chief Financial Officer Conference Call Participants Stephanie Davis – Barclays Charles Rhyee – TD Cowen Lisa Gill – J.P. Morgan Scott Schoenhaus – KeyBanc Stan Berenshteyn – Wells Fargo Securities Sean Dodge – RBC Capital Markets Jailendra Singh – Truist Securities Allen Lutz – ...